S&P 500 7,580.07 −1.82%
Nasdaq 25,437.00 −2.86%
S&P/TSX 35,620.03 −1.74%
Apple 344.63 −1.23%
Nvidia 204.64 −4.22%
Microsoft 521.91 −1.55%
Shopify 220.37 −5.70%
Royal Bank 283.93 −1.49%
CAD/USD 0.7154 +0.06%
CLOSED · 01:55 ET
Market ClerkRecap
Mon Nov 2 · markets closed1 signal on Oct 31129 insider buys this week · $10BCIRO short report next: Nov 14The week ahead

UPB

Upstream Bio, Inc.
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
3.41
+0.14 +4.28%
USD · close Oct 30

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose UPB in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
Decheng Capital Global Life Sciences Fund IV, L.P. and 2 related4.9%
SCHEDULE 13G/A · filed Oct 29 · passive · EDGAR ↗

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch UPB. Know when insiders buy.
One email the day a filing lands. Free.